Author:
de Wit Niek,Keszthelyi Daniel
Reference8 articles.
1. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis;Oka;Lancet Gastroenterol Hepatol,2020
2. Efficacy of soluble fibre, antispasmodic drugs, and gut–brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis;Black;Lancet Gastroenterol Hepatol,2020
3. British Society of Gastroenterology guidelines on the management of irritable bowel syndrome;Vasant;Gut,2021
4. Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase;Ford;Lancet,2023
5. Bowel disorders;Mearin;Gastroenterology,2016